GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH): Matt Sirovich And Jeremy Mindich’s Scopia Capital filed an amended 13D.
You can check out Scopia Capital’s latest holdings and filings here.
Please follow Scopia Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Scopia Capital or update its stock holdings.
Follow Matt Sirovich And Jeremy Mindich's Scopia Capital
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Scopia Capital Management | 0 | 2,846,690 | 0 | 2,846,690 | 2,846,690 | 11.29% |
| Scopia Management, Inc | 0 | 2,846,690 | 0 | 2,846,690 | 2,846,690 | 11.29% |
| Matthew Sirovich | 0 | 2,846,690 | 0 | 2,846,690 | 2,846,690 | 11.29% |
| Jeremy Mindich | 0 | 2,846,690 | 0 | 2,846,690 | 2,846,690 | 11.29% |
Follow Matt Sirovich And Jeremy Mindich's Scopia Capital
Page 1 of 12 – SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
| GW Pharmaceuticals PLC |
| (Name of Issuer) |
| American Depositary Shares, each representing 12 Ordinary Shares, par value £0.001 per share |
| (Title of Class of Securities) |
| 36197T103 |
| (CUSIP Number) |
| August 31, 2017 |
| (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
[X] Rule
13d-1(b)
[ ] Rule
13d-1(c)
[_] Rule
13d-1(d)
_________
| (1) | The remainder of this cover page shall be filled out for a reporting
|
The information required in the remainder of this cover
page shall not be deemed to be “filed’ for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
